Study of GS-3242 in Participants With HIV-1; Substudy-05

Clinical trial NCT07001319 · COMPLETED

Trial details

NCT number: NCT07001319
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2025-05-29
Primary completion: 2026-03-03
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.